In breakthrough Alzheimer’s discovery, research team finds new targets and biomarkers for potential novel therapies

Estimated reading time: 1 minutes

• About The Author

Scientists explain how the amyloid beta deposits long known to build up in the brains of Alzheimer’s patients serve as a kind of scaffold for the accumulation of other proteins. Because many of these proteins have known signaling functions, their presence around the amyloid accumulations, known as plaques, could be the culprit causing brain cell damage rather than the amyloid itself.

About The Author

See author's posts

Trending

Google Ranking Factors and Marketing KPIs